Ventas Inc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Ventas Inc (VTR). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| SHOP | $2.65B 65.4% | $2.96B 66.5% · +11.6% | $3.37B 69.2% · +14.0% | $4.28B 74.0% · +26.8% |
| Outpatient medical and research portfolio (OM&R) | $803.6M 19.8% | $869.7M 19.6% · +8.2% | $877.6M 18.0% · +0.9% | $897.9M 15.5% · +2.3% |
| NNN | $598.2M 14.8% | $619.2M 13.9% · +3.5% | $622.1M 12.8% · +0.5% | $601.6M 10.4% · -3.3% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by region
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| United States | $3.38B 89.1% | $3.36B 87.9% · -0.5% | $3.65B 88.5% · +8.6% | $4.00B 89.0% · +9.6% | $4.37B 88.7% · +9.1% | $5.21B 89.3% · +19.3% |
| Canada | $389.2M 10.3% | $434.9M 11.4% · +11.7% | $449.1M 10.9% · +3.3% | $464.8M 10.3% · +3.5% | $526.6M 10.7% · +13.3% | $552.9M 9.5% · +5.0% |
| United Kingdom | $24.8M 0.7% | $29.9M 0.8% · +20.8% | $27.8M 0.7% · -7.3% | $28.9M 0.6% · +4.0% | $30.7M 0.6% · +6.4% | $71.2M 1.2% · +131.7% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.